The effectiveness of thiamine on cognitive symptoms after electroconvulsive therapy in patients with mood disorders
Phase 3
Recruiting
- Conditions
- Cognitive Symptom.Other symptoms and signs involving cognitive functions and awareness
- Registration Number
- IRCT20190525043700N3
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
Patients aged 20-50 years with depressive phase of mood disorders
Exclusion Criteria
Patients with a history of alcohol and other substance use in the month before enrollment
Epilepsy
Mental retardation
Cognitive disorders such as delirium and dementia
History of thiamine use in the month before enrollment
Anemia
Malnutrition
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive ability. Timepoint: It will be measured 24 hours before and 24 hours after the end of electroconvulsive therapy sessions and also two months after the end of electroconvulsive therapy. Method of measurement: Addenbrooke's Cognitive Examination.
- Secondary Outcome Measures
Name Time Method